INTRODUCTION

Since the description of O-linked N-acetylglucosamine (O-
Protein O-GlcNAcylation is highly dynamic, and the cycle of addition/removal of the sugar moiety is rapid, analogous to protein phosphorylation/dephosphorylation catalyzed by kinases and phosphatases (2) . Indeed, existing evidence suggests that this modification has a 'yin-yang' relationship with protein phosphorylation in some cases (4). Many O-GlcNAcylation sites have been mapped to phosphorylation sites or adjacent sites (5, 6, 7) . Such spatial localization indicates that O-GlcNAc may regulate the target protein by competing with protein kinases (4). Recent studies using phosphatase and kinase inhibitors have provided direct evidence for a general reciprocal relationship between O-GlcNAcylation and phosphorylation on some proteins (8, 9) .
conversely, blocking the GlcNAc residues with lectin wheat germ agglutinin (WGA) suppresses the transcriptional activity (10) . O-GlcNAcylation of Sp1 also controls its degradation by the proteosome (15) . Hyperglycermia induced superoxide production increases Sp1 glycosylation resulting in the activation of genes that contribute to the pathogenesis of diabetes (16) .
O-GlcNAc transferase (OGT), which transfers GlcNAc from the donor substrate UDPGlcNAc to target proteins, has been purified and cloned from several species including human, rat and C. elegans (17, 18, 19) . It does not share any significant homology with any other known proteins including glycosyltransferases, and is highly conserved from C. elegans to human.
Disruption of the ogt gene is lethal in mouse embryonic stem cells, further underlining the importance of O-GlcNAc modification in cellular functions (20) . O-GlcNAcase, the enzyme that removes O-GlcNAc from such proteins, was purified several years ago from rat spleen (21) . It is a neutral cytosolic β-glucosaminidase or hexosaminidase C (EC 3.2. 
EXPERIMENTAL PROCEDURES
Purification of O-GlcNAcase from Bovine
Brain-All chromatographic materials were purchased from Amersham-Pharmacia Biotech (Piscataway, NJ). Purification procedure is substantially modified from that of Dong and Hart (21) . All steps were conducted at 4°C or on ice.
Step 1 Step 2. Ammonium Sulfate Precipitation-The cytosolic supernatant was subjected to 30-50% ammonium sulfate precipitation. The pellet was resuspended in 500 mL of Buffer A (20 mM sodium phosphate, pH 7.5, 5 mM 2-mercaptoethanol), and centrifuged to clarify the solution. The solution was then thoroughly dialyzed against buffer A and centrifuged again to eliminate any insoluble materials that had resulted from dialysis.
Step 3. DE52 Cellulose Ion Exchange Chromatography-The dialyzed sample was loaded onto a DE52 column (900 mL bed vol) at a flow rate of 2 mL/min using a peristaltic pump. After Step 4. Concanavalin A-Sepharose 4B Chromatography-MgCl 2 was added to the pooled fractions at a final concentration of 1 mM. The preparation was then applied to a Con A column (60 mL) equilibrated in Con A buffer (20 mM sodium phosphate, pH 7.5, 5 mM 2-mercapoethanol, 150 mM NaCl, 1 mM MgCl 2 ). The column was washed with 200 mL of Con A buffer. The flow through and the wash were combined.
Step 5. Affinity Blue A Chromatography-The enzyme solution from Step 4 was concentrated by 60% ammonium sulfate precipitation, dialyzed and applied three times to a Blue A sepharose column (25 mL) equilibrated in Buffer A. Again the activity was present in the flow through fraction. The protein was pooled and clarified by centrifugation.
Step 6. Re-chromatography on DE52 Column-The sample from
Step 5 was injected to the DE52 cellulose column (same size as above) and protein was eluted with a linear gradient of 50-350 mM NaCl in 4 L of buffer A. Activity was recovered as in Step 3 and precipitated with 60% ammonium sulfate. The pellet was resuspended in 20 mL of Mono-Q Buffer (20 mM Tris pH 7.5, 5 mM 2-mercaptoethanol, 10% glycerol,1 mM EDTA plus protease inhibitor cocktail (Pics 1 & 2) (22) and 1 mM PMSF, dialyzed and clarified by centrifugation.
Step 7. Native Polyacrylamide Gel Electrophoresis-Native PAGE was performed using a preparative Prepcell apparatus (Bio-Rad. Hercules, CA). The sample from Step 6 was divided into 3 equal volumes (45 mg protein each) and loaded batch-wise onto a 6% native polyacrylamide gel (5 cm long separating gel). The gel was run for 24 h at 12 watts constant power. Protein was eluted in Mono-Q buffer at a flow rate of 0.75 mL/min. Five min fractions were collected and assayed for protein content and enzyme activity.
Step 8 were separated into cytoplasmic and nuclear fractions as described (26) 
RESULTS
Native Polyacrylamide Gel Electrophoresis Aides in O-GlcNAcase Purification from
Bovine Brain-Historically, O-GlcNAcase, or neutral hexosaminidase C, has been difficult to purify. For example, an early report described a purification of only 25-40 fold from bovine brain despite the extensive use of chromatographic steps (27) . While in rat brain, the enzyme has been purified over 2,000 fold to a major band (28). More recently, renewed effort has gone into its purification from rat spleen and bovine brain in the pursuit to cloning the cDNA (21, 29).
We have taken an approach, partly based on published literature (21) The final preparation still shows seven well defined bands on SDS-PAGE following silver staining, even after extensive purification (Fig. 2) . We do not understand the basis for this difficulty, but we have observed that the peaks for O-GlcNAcase activity are very broad throughout the purification procedure ( Fig. 1) . One example of this is illustrated in the Mono-Q step, where the general protein peaks are sharp but yet the activity peak spreads over 50 mL (Fig.   1c) . We have also tried ion exchange on Superose Q and hydroxyapatite columns or hydrophobic interaction chromatography on a phenyl sepharose column. They, too, give poor separations or the enzyme binds very tightly to phenyl sepharose resulting in >50% activity loss (data not shown).
Mass Spectrometry Identifies O-GlcNAcase on SDS-PAGE Gel-
The seven bands on the silver stained SDS-PAGE gel were excised individually, digested with trypsin and sequenced by electrospray ms/ms. The fragmentation data were used to search protein and DNA databases.
This approach identified six proteins with known functions in six of the bands (Fig. 2) comparisons of O-GlcNAcase activity and protein patterns on the SDS gels of different pools during the purification procedure indicated that this protein was one of only two bands that corresponded with activity (The other band was #1 in Fig. 2 , data not shown). We therefore hypothesized that this may be the O-GlcNAcase, and cloned the cDNA. Further characterization of the expression product of the cDNA confirmed that band 2 on Fig. 2 and Drosophila are shown in Fig. 3 . In a pair-wise alignment, the human sequence shares 55%
was, indeed, O-
GlcNAcase (see below).
O-GlcNAcase is Unique and Conserved during Evolution-
and 43% homology with that of Drosophila and C. elegans, respectively, while Drosophila and C. elegans are 43% similar. Close inspection of the sequences indicate that the N-terminal ~400 and the C-terminal ~350 amino acids in the human sequence is conserved to a higher degree.
These two domains are separated by a highly variable region of ~150 amino acids. Another feature is that most of the aromatic residues are conserved among the species. For example, out of the 13 Trp residues found in the human sequence, 9 are invariant in Drosophila and C.
elegans, two are conservative (substituted by Tyr or Phe), and only two are variable.
The O-GlcNAcase sequence is conserved at a strikingly higher level in mammals. Four overlapping EST sequences from cow, which cover 46% of the human protein, show that these two species are 100% identical in these regions (BE481597, BE588694, BF043559 and Transient transfection resulted in a 6-fold increase in O-GlcNAcase activity over endogenous activity in the cells (Fig. 4a) . After nickel affinity purification, the activity from the OGlcNAcase transfected cells was 230 nmol/min/mg protein, but was not detectable from control transfected cells (Fig. 4b) . These data show that the activity is due to overexpression from the plasmid. Fig. 4c shows that a distinct band of the correct molecular weight (135 kD) was isolated after nickel purification from transfected cells. This band was immunoreactive the Xpress antibody, which was specific for a peptide sequence in the overexpressed protein.
Recombinant O-GlcNAcase has Distinct Properties from Lysosomal -hexosaminidase-
We further characterized the properties of the cloned O-GlcNAcase and compared them with those of lysosomal β-hexosaminidase purified from bovine kidney. As expected, the lysosomal β-hexosaminidase had an acidic pH optimum (pH 3.5-5.5) with little activity at pH 7.0 or above (Fig. 5a ). On the other hand, the cloned O-GlcNAcase had a pH optimum of 5.7-7.0, and retained significant activity (~30%) at pH 7-8. This pH profile is consistent with the expected localization of O-GlcNAcase in the cytoplasm and the nucleus.
The two enzymes also responded differently to inhibitors. GalNAc, a widely used inhibitor of acidic β-hexosaminidase, inhibited the lysosomal enzyme 50% at 5.0 mM and 88% at 50 mM. The cloned O-GlcNAcase was not inhibited at all by GalNAc up to 50 mM (Fig. 5b) .
GlcNAc and its synthetic analogue PUGNAc inhibited both enzymes but were more potent with the O-GlcNAcase (Fig. 5 c, d) . 
Recombinant O-GlcNAcase Shows Strict Substrate Specificity for -linked GlcNAc-O-
GlcNAcase also differed from lysosomal β-hexosaminidase in substrate requirements. In the in vitro assays, purified recombinant O-GlcNAcase cleaved only pNP-β-GlcNAc, but not pNP-β-GalNAc or pNP-α-GlcNAc (Fig. 6) . The activity using the latter two compounds as substrates was not detectable. This substrate specificity was in contrast to the lysosomal β-hexosaminidase, which also cleaved pNP-β-GalNAc, albeit with slightly lower efficiency compared to pNP-β- (Fig. 7a and b) , but did successfully cleave GlcNAc from the peptide, as judged by the expected shift in molecular weight (1069.8 to 866.6, 1091.8 to 888.6) ( Fig. 7 c and d) . was distributed in both the cytoplasm and the nucleus. However, when O-GlcNAcase was overexpressed, it was predominantly found in the cytoplasm (Fig. 8a) . We also probed for its localization by Western blots (Fig. 8b) . Retinoblastoma protein (Rb) and α-tubulin, which were exclusively localized in the nucleus and cytoplasm, respectively, were used as markers. In agreement with activity assays, overexpressed O-GlcNAcase protein was only detected in the cytoplasm of overexpressed cells. Northern blot analysis showed only one transcript of ~5.5 kb for O-GlcNAcae (Fig. 9) . Exposing the film for extended time (32 h) did not reveal any additional bands (data not shown). The gene was expressed in every tissue on the blot, but was the highest in the brain, followed by placenta and pancreas. Lung and liver had the lowest expression (Fig. 9 ). This pattern of expression largely agrees with that of the ogt gene. ogt is expressed the highest in the pancreas, followed by heart, brain and placenta, but the lowest in lung, liver and kidney (18). Unlike ogt gene which is The predicted localization of O-GlcNAcase by sequence analysis is consistent with the literature that O-GlcNAc modification and OGT are found both in the cytoplasm and nucleus (19, 36) . It is therefore somewhat unexpected to find that overexpressed O-GlcNAcase in Cos-7 cells is almost exclusively localized to the cytoplasm (Fig. 8) . Nevertheless, it is not uncommon that overexpressed proteins often form aggregates in the cytoplasm, and can not be correctly 
GlcNAc.
O-GlcNAcase Cleaves O-GlcNAc from Glycopeptides-
O-GlcNAcase Has One Transcript in Human Tissues
